<code id='70B5BB1CD7'></code><style id='70B5BB1CD7'></style>
    • <acronym id='70B5BB1CD7'></acronym>
      <center id='70B5BB1CD7'><center id='70B5BB1CD7'><tfoot id='70B5BB1CD7'></tfoot></center><abbr id='70B5BB1CD7'><dir id='70B5BB1CD7'><tfoot id='70B5BB1CD7'></tfoot><noframes id='70B5BB1CD7'>

    • <optgroup id='70B5BB1CD7'><strike id='70B5BB1CD7'><sup id='70B5BB1CD7'></sup></strike><code id='70B5BB1CD7'></code></optgroup>
        1. <b id='70B5BB1CD7'><label id='70B5BB1CD7'><select id='70B5BB1CD7'><dt id='70B5BB1CD7'><span id='70B5BB1CD7'></span></dt></select></label></b><u id='70B5BB1CD7'></u>
          <i id='70B5BB1CD7'><strike id='70B5BB1CD7'><tt id='70B5BB1CD7'><pre id='70B5BB1CD7'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:2
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Truvian presents data for its desktop blood
          Truvian presents data for its desktop blood

          TruvianHealthemployeewithaplateholdingreagentsusedtomeasurecommonlytestedbloodmarkers.TruvianSANDIEG

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Adam's Take: Intra

          MollyFerguson/STATIamoneweekawayfromthelaunchofmyweeklyemailnewsletter!It’scalledAdam’sBiotechScorec